Behiye Özcan

730 total citations
31 papers, 527 citations indexed

About

Behiye Özcan is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, Behiye Özcan has authored 31 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Physiology and 6 papers in Surgery. Recurrent topics in Behiye Özcan's work include Pancreatic function and diabetes (5 papers), Diet and metabolism studies (4 papers) and Diabetes and associated disorders (4 papers). Behiye Özcan is often cited by papers focused on Pancreatic function and diabetes (5 papers), Diet and metabolism studies (4 papers) and Diabetes and associated disorders (4 papers). Behiye Özcan collaborates with scholars based in Netherlands, United Kingdom and Germany. Behiye Özcan's co-authors include Eric J.G. Sijbrands, Lucy Baldeón, Pieter J. M. Leenen, Harm de Wit, Hemmo A. Drexhage, Laura Grosse, A. van Oudenaren, Fernando Sempértegui, Karin Weigelt and Wilma B. Freire and has published in prestigious journals such as PLoS ONE, Diabetes Care and Scientific Reports.

In The Last Decade

Behiye Özcan

30 papers receiving 524 citations

Peers

Countries citing papers authored by Behiye Özcan

Since Specialization

Citations

This map shows the geographic impact of Behiye Özcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behiye Özcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behiye Özcan more than expected).

Fields of papers citing papers by Behiye Özcan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behiye Özcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behiye Özcan. The network helps show where Behiye Özcan may publish in the future.

Co-authorship network of co-authors of Behiye Özcan

This figure shows the co-authorship network connecting the top 25 collaborators of Behiye Özcan. A scholar is included among the top collaborators of Behiye Özcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behiye Özcan. Behiye Özcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	EAAT3 modulation: A potential novel avenue towards remyelination in multiple sclerosis 2025 ·Biomedicine & Pharmacotherapy ·(unknown), Melissa Schepers, Assia Tiane, Vijay Kumar, (unknown), Ben Rombaut, (unknown), Tim Vangansewinkel, Anna Li, Esther Wolfs, Behiye Özcan, (unknown), Pablo R. Moya, David B. Sauer, Hanne Diliën, Niels Hellings, Rudy Schreiber, Tim Vanmierlo	1
2	Influence of metabolic state and body composition on the action of pharmacological treatment of migraine 2024 ·The Journal of Headache and Pain ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Pavel Řehulka, (unknown), (unknown), S. Vigneri, Behiye Özcan, Antoinette MaassenVanDenBrink	14
3	The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands 2024 ·Journal of Clinical & Translational Endocrinology ·(unknown), Eline M. Bunnik, Behiye Özcan, Robert Zietse, Emma K. Massey	1
4	Clinical Translation and Implementation of a Bioartificial Pancreas Therapy: A Qualitative Study Exploring the Perspectives of People With Type 1 Diabetes 2024 ·Transplantation Direct ·(unknown), (unknown), Behiye Özcan, Robert Zietse, Eline M. Bunnik, Emma K. Massey	2
5	Bariatric surgery in a patient with cystic fibrosis and diabetes: A case report 2023 ·Journal of Cystic Fibrosis ·(unknown), Margreet A. E. M. Wagenmakers, Mandy van Hoek, Jan A. Apers, Menno M. van der Eerden, Behiye Özcan	3
6	The (cost) effectiveness of a very low-energy diet intervention with the use of eHealth in patients with type 2 diabetes and obesity: study protocol for a randomised controlled non-inferiority trial (E-diet trial) 2023 ·Trials ·(unknown), Behiye Özcan, Mandy van Hoek, (unknown), (unknown), Joost van Rosmalen, Elisabeth F. C. van Rossum, Kirsten A. Berk	0
7	The effect of monomeric and oligomeric FLAVAnols in patients with type 2 diabetes and microalbuminuria (FLAVA-trial): A double-blind randomized controlled trial 2021 ·Clinical Nutrition ·(unknown), Adrie J.M. Verhoeven, Monique Mulder, Reinier Timman, Behiye Özcan, (unknown), (unknown), (unknown), Willem A. Dik, Eric J.G. Sijbrands, Kirsten A. Berk	4
8	Overweight and obesity in type 1 diabetes is not associated with higher ghrelin concentrations 2021 ·Diabetology & Metabolic Syndrome ·Behiye Özcan, Patric J. D. Delhanty, Martin Huisman, Jenny A. Visser, Sebastian Neggers, Aart Jan van der Lely	1
9	High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort 2020 ·BMJ Open Diabetes Research & Care ·(unknown), Femmie de Vegt, Evertine J. Abbink, Femke Rutters, Miranda T. Schram, Melanie M. van der Klauw, Bruce H. R. Wolffenbuttel, Sarah E. Siegelaar, J. Hans DeVries, Eric J.G. Sijbrands, Behiye Özcan, Harold W. de Valk, (unknown), Nicolaas C. Schaper, Coen D.A. Stehouwer, Petra J. M. Elders, Cees J. Tack, Bastiaan E. de Galan	49
10	Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation 2020 ·International Journal of Molecular Sciences ·(unknown), Tamara Hoppenbrouwers, Cristina Martinez-Torres, (unknown), Behiye Özcan, Mandy van Hoek, Frank W.G. Leebeek, D.C. Rijken, Gijsje H. Koenderink, Moniek P.M. de Maat	17
11	Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort 2020 ·BMJ Open Diabetes Research & Care ·Marit de Jong, (unknown), Simone J. S. Sep, Behiye Özcan, Femke Rutters, Eric J.G. Sijbrands, Petra J. M. Elders, Sarah E. Siegelaar, J. Hans DeVries, Cees J. Tack, Mariëlle A Schroijen, Harold W. de Valk, Evertine J. Abbink, Coen D.A. Stehouwer, Ingrid M. Jazet, Bruce H. R. Wolffenbuttel, Sanne A. E. Peters, Miranda T. Schram	18
12	Group cognitive behavioural therapy and weight regain after diet in type 2 diabetes: results from the randomised controlled POWER trial 2018 ·Diabetologia ·Kirsten A. Berk, (unknown), Adrie J.M. Verhoeven, Monique Mulder, Behiye Özcan, Adriaan van ’t Spijker, Reinier Timman, Jan J.V. Busschbach, Eric J.G. Sijbrands	27
13	Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D 2016 ·Diabetology & Metabolic Syndrome ·Lucy Baldeón, Karin Weigelt, Harm de Wit, Behiye Özcan, A. van Oudenaren, Fernando Sempértegui, Eric J.G. Sijbrands, Laura Grosse, Anton Jan van Zonneveld, Hemmo A. Drexhage, Pieter J. M. Leenen	24
14	Predictors of Diet-Induced Weight Loss in Overweight Adults with Type 2 Diabetes 2016 ·PLoS ONE ·Kirsten A. Berk, Monique Mulder, Adrie J.M. Verhoeven, Herman van Wietmarschen, (unknown), Linette Pellis, Adriaan van ’t Spijker, Reinier Timman, Behiye Özcan, Eric J.G. Sijbrands	7
15	Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation 2015 ·PLoS ONE ·Lucy Baldeón, Karin Weigelt, Harm de Wit, Behiye Özcan, A. van Oudenaren, Fernando Sempértegui, Eric J.G. Sijbrands, Laura Grosse, Anton Jan van Zonneveld, Hemmo A. Drexhage, Pieter J. M. Leenen	24
16	Lipid droplets hypertrophy: a crucial determining factor in insulin regulation by adipocytes 2015 ·Scientific Reports ·Bahram Sanjabi, Monireh Dashty, Behiye Özcan, (unknown), Mehran Rahimi, Manlio Vinciguerra, (unknown), Saad Al-Lahham, Fareeba Sheedfar, Theo G. van Kooten, C. Arnold Spek, Ajda T. Rowshani, J.J.L. van der Want, René A. Klaassen, Eric J.G. Sijbrands, Maikel P. Peppelenbosch, Farhad Rezaee	26
17	Failing beta-cell adaptation in South Asian families with a high risk of type 2 diabetes 2014 ·Acta Diabetologica ·(unknown), Behiye Özcan, T. Rietveld, (unknown), Aaron Isaacs, Janneke G. Langendonk, Felix W.M. de Rooij, Eric J.G. Sijbrands	20
18	Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients 2014 ·PLoS ONE ·Lucy Baldeón, Karin Weigelt, Harm de Wit, Behiye Özcan, A. van Oudenaren, Fernando Sempértegui, Eric J.G. Sijbrands, Laura Grosse, Wilma B. Freire, Hemmo A. Drexhage, Pieter J. M. Leenen	99
19	The Prevention Of WEight Regain in diabetes type 2 (POWER) study: the effectiveness of adding a combined psychological intervention to a very low calorie diet, design and pilot data of a randomized controlled trial 2012 ·BMC Public Health ·Kirsten A. Berk, (unknown), Behiye Özcan, Adriaan van’t Spijker, Jan J.V. Busschbach, Eric J.G. Sijbrands	12
20	The Diabetes Pearl: Diabetes biobanking in The Netherlands 2012 ·BMC Public Health ·(unknown), Miranda T. Schram, Evertine J. Abbink, Wanda M. Admiraal, (unknown), F. Holleman, Giel Nijpels, Behiye Özcan, Hanno Pijl, Nicolaas C. Schaper, Eric J.G. Sijbrands, (unknown), Cees J. Tack, Harold W. de Valk, Bruce H. R. Wolffenbuttel, Coen D.A. Stehouwer, Joost Dekker	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact